You just read:

Actinium Announces Update Including IP and New Data from Novel Combination of Actimab-A and Venetoclax Accepted for Poster Presentation at AACR Annual Meeting

News provided by

Actinium Pharmaceuticals, Inc.

Mar 20, 2019, 08:00 ET